Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice

• Príomhchruthaitheoirí: Cristina Villanueva-Bueno (Údar), Elena Montecatine-Alonso (Údar), Francisco Jiménez-Parrilla (Údar), María González-López (Údar), Silvia Manrique-Rodríguez (Údar), Francisco Moreno-Ramos (Údar), Carme Cañete-Ramírez (Údar), Elisenda Dolz (Údar), Ana García-Robles (Údar), José Manuel Caro-Teller (Údar), María Teresa Moral-Pumarega (Údar), Elena Bergon-Sendin (Údar), María Teresa Gómez-Trevecedo Calvo (Údar), Carmen Gallego-Fernández (Údar), Concepción Álvarez del Vayo-Benito (Údar), Marta Mejías-Trueba (Údar), María Victoria Gil-Navarro (Údar), Paediatric Antimicrobial Defined Daily Dose Study Group (KiDDDs) (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2023-03-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background: Currently, there is no validated method for estimating antimicrobial consumption in the neonatal population, as it exists for adults using Defined Daily Doses (DDD). In neonatology, although there are different methods, each one with advantages and disadvantages, there is no unified crit...